NPPB and hydrops fetalis: Third, because post-hoc analyses of data obtained from the SAVOR trialshowed that the increased risk of HF was mainly found in patients with elevatedNT-proBNP baseline levels or prior HF6, we examined the risk of HHFamong patients with or without prior HF in this study.